Safety and Efficacy of Sovateltide (IRL-1620) in a Multicenter Randomized Controlled Clinical Trial in Patients with Acute Cerebral Ischemic Stroke

ConclusionSovateltide was safe and well-tolerated and resulted in improved neurological outcomes in patients with acute cerebral ischemic stroke 90 days post-treatment.Trial RegistrationThe study is registered at CTRI/2017/11/010654 and NCT04046484.

Source: CNS Drugs - January 11, 2021 Category: Neurology Source Type: research